AzTrials
AzTrials

Dental AnxietySEREINNCT07273968

Clinical Study Evaluating the Effect of Virtual Reality on Reducing Patients' Anxiety During Wisdom Teeth Extraction

A study testing Virtual reality HypnoVR® (VR headset + hypnotic software) in people with Dental Anxiety and Third Molar Extraction, run by University Hospital, Strasbourg, France at 1 site in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Dental anxiety is common during third molar extractions and may exacerbate pain perception. Local anesthesia does not prevent exposure to stress-inducing stimuli. Virtual reality (VR) combined with hypnotic scripts (HypnoVR®) provides immersive multisensory distraction. Read more about this study

Who is it for?
Ages 18 to 65 years
What is being tested?
Virtual reality HypnoVR® (VR headset + hypnotic software)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteFrance
Study dates
10 Apr 2026to 1 Sep 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age 18-65
  • Indication for extraction of 4 wisdom teeth or ≥2 mandibular wisdom teeth
  • ASA I-II
  • Written informed consent.

Who cannot join

  • Visual/hearing impairment
  • Psychiatric disorders or psychotropics (<8 weeks)
  • Claustrophobia
  • Heavy smoking >10 cig/day
  • Previous radiotherapy (jaw)
  • ASA III-IV
Show all 13Show fewer
  • Pregnancy
  • Antithrombotic therapy
  • Chemotherapy
  • Bisphosphonates
  • Uncontrolled diabetes
  • Severe anxiety requiring GA or pharmacological sedation
  • No health insurance affiliation.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

France1 site, 1 recruiting
  • Pierre KLIENKOFF

    Strasbourg, 67000

    Pierre KLIENKOFF, MD, 03 88116768, pierre.klienkoff@chru-strasbourg.fr

    Recruiting

Other trials in France

About this study

Official title: Clinical Study Evaluating the Effect of Virtual Reality on Reducing Anxiety in Patients Undergoing Wisdom Teeth Extraction

Dental anxiety is common during third molar extractions and may exacerbate pain perception. Local anesthesia does not prevent exposure to stress-inducing stimuli. Virtual reality (VR) combined with hypnotic scripts (HypnoVR®) provides immersive multisensory distraction. This study tests whether VR reduces perioperative anxiety and postoperative pain compared to local anesthesia alone.

Being tested
Virtual reality HypnoVR® (VR headset + hypnotic software), Control Group (No VR)

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Virtual reality HypnoVR® (VR headset + hypnotic software)Device

    CE-marked class I device combining VR immersion with hypnotic text and music therapy to reduce anxiety and pain during oral surgery.

  • Control Group (No VR)Other

    local anesthesia alone (no VR)

Study groups in NCT07273968
Study groupRoleWhat they receive
Virtual Reality GroupExperimentalWisdom tooth extraction under local anesthesia with immersive VR hypnosis (HypnoVR® system).
Receives: Device: Virtual reality HypnoVR® (VR headset + hypnotic software)
Control Group (No VR)Active comparatorWisdom tooth extraction under local anesthesia alone (no VR).
Receives: Other: Control Group (No VR)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Anxiety reduction (MDAS questionnaire)

    5-item validated scale, score range 5-25

    Measured: Day 1

  2. Anxiety reduction (MDAS questionnaire)

    5-item validated scale, score range 5-25

    Measured: Month1

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Dec 2025
  2. Study start10 Apr 2026
  3. Primary completion1 Sep 2027 (estimated)
  4. Study completion1 Sep 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07273968
Sponsor's protocol ID
9832
Acronym
SEREIN
Status last verified
Aug 2026
First submitted
25 Nov 2025
Last updated
20 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Virtual reality HypnoVR® (VR headset + hypnotic software) in people with Dental Anxiety and Third Molar Extraction, run by University Hospital, Strasbourg, France at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 20 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Anxiety reduction (MDAS questionnaire) (time frame: Day 1). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Aug 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in